Your search matched 23 results
DATA-DRIVEN EXPECTATIONS | Perspectives
Major disrupters in the pharmaceutical industry have put the spotlight on quantifying value and measuring impact.
BIGGEST LESSONS LEARNED IN 2016 | In The Media
With so many different options for platforms and various approaches to data management, the most difficult challenge of 2016 was getting data to work harder for pharma companies.
Live from Cannes Lions Health: That headline was one of the first comments in a panel on the world’s second largest healthcare market.
inVentiv Health Communications, a purpose-built collective of agencies focused on supporting health and biopharmaceutical innovators, and Concentric, Inc., a software company, today announced an exclusive partnership to license a simulator technology.
Orbita, a company that helps people create voice-driven experiences for technology like Amazon Alexa and Google Home, has teamed up with the clinical trial data firm ERT to start to uncover ways in which voice technology can play a role in clinical trials.
Europe | Region
Mark Baglin, Vice President of Global Marketing at Alnylam Pharmaceuticals, works in ultra ultra rare diseases, like Hereditary ATTR Amyloidosis.
It’s 2017, and we’ve come to the point where the digital and physical worlds have become one.
Lilly & Harvard Pilgrim Healthcare's CEOs shared their thoughts on value-based arrangements between pharma and payers
Fabrizio Caranci, Director of Channel Innovation at Merck, started out with this super fact from John Chambers, CEO at Cisco: by 2020 over 30 billion objects will wirelessly be connected to the internet.
Understanding a consumer need for easier access to healthcare, researchers from the University of California in San Francisco are using data from a recent study to explore a new smartphone app that can provide a diagnosis without a trip to the doctor.
Today, consumers are empowered to consider all of the information and varieties surrounding brands and their products.
Digital therapeutics, or DTx, are distinct from digital health products, and are driven by software programs that can be prescribed to prevent, manage, or treat a medical disorder or disease, as stated by the Digital Therapeutics Alliance.
Artery is a medical imaging platform that has recently been approved to help doctors diagnose heart problems.
In 2003, there were 15 of us at Biosector 2 (B2), an open floor plan, a few dogs lounging around, daily lunch provided from our favorite -- Chelsea market and great surround sound music.
The industry and the Department of Health and Human Services presented different visions of what greater pricing transparency looks like in the future, complete with separate proposals of how and what information should be shared with consumers.
eBook Provides Biopharma Decision Makers With What’s-Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead
No matter whether you were the lone staffer in your office or relaxing on a beach somewhere this past week, we’ve got the run down on the latest healthcare headlines—the good, the bad and the ugly—to help you get you back up to speed.
I went to YouTube this morning to watch the newest Samsung Galaxy commercial, hoping it would be as funny as my husband promised.
Are U.S. sheriffs PhRMA’s new spokespeople?
From potential drug pricing policies to investor interest in life science companies, there’s a lot of talk around money and medicines right now.
With the year rapidly coming to a close, we’ve decided to take you on a trip down memory lane to recap the biggest stories and trends of 2017.
In an age of increasingly accountable marketing, there’s a continuing focus on making this spend as effective as possible, and we see two trends in the way that organisations are approaching their meeting investments.